| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2004;44:e13.)
© 2004 American Heart Association, Inc.
Letters to the Editor |
Hypertension Research Unit, University of Carabobo Medical School, Valencia, Venezuela
To the Editor:
The electrocardiographic patterns of left ventricular hypertrophy or left ventricular strain have received considerable attention for investigators in the last half a century. A variety of ECG measurements, involving QRS voltage (µV or mV) and time-interval, have been used to define left ventricular hypertrophy (LVH) in the Sokolow-Lyon (1949), Cornell (1985), and Cornell product (1995) criteria.13 Both QRS interval (0.04 milliseconds) and ST deviation (µV) improve the sensitivity and specificity of the voltage criteria.3 In general, these ECG criteria have been validated by echocardiography, a method that overestimates left ventricular mass relative to MRI.
In the August issue of Hypertension, K. Alfakih et al presented the first new gender-specific ECG criteria based on cardiac MRI.4 They found that at a specificity of 95%, the Sokolow-Lyon product enhances sensitivity in females (26.2%), Cornell criterion in males (26.2%), and Cornell product criteria in both males and females (25.0%, 23.8%). These results were based on ECG recorded at 25 mm/s and at 1 mV/cm standardization. However, a gross mistake is evident in the methods and results (Table 1 of Alfakih et al): LVH voltage was defined as a Sokolow-Lyon voltage (SV1+RV5 or RV6)
35 mV (instead of
35 mm), Cornell voltage (RaVL+ SV3)
28 mV for men and
20 mV for women (versus
28 mm and
20 mm), and Cornell product [(RaVL+SV3)·QRS duration] >2440 mV · ms (versus
2400 mm · ms). Numbers in parenthesis correspond to the actual values for such indexes.13
The authors even present an incorrect version of the LIFE study reported in Lancet 2002, when quoting QRS interval and Cornell voltages "with an adjustment of 8 mV in females and a partition value of 2440 mV · ms".
Because QRS amplitudes were expressed in 1 mm=1mV, instead of 100 µV or 0.1 mV/mm, QRS voltages in Alfakih et als Table 1 do not represent Sokolow, Cornell, or Cornell product criteria for any sex group, with or without LVH. These measurements should be corrected and expressed in electrical units (µV or mV · ms), a reliable parameter for the gender-specific LVH. This unexpected "error" from a Research Heart Center probably arises from the equivocal use of metrical (1 mm) instead of electrical (100 µV=1 mm) units in virtually all medical and ECG textbooks, even after 6 decades of Ashman works on ECG units: 1 mm square=100 µV · 0.04 ms,5 which may explain an identical mistake in Cornell Voltage-duration product (2483 to 3594 mV · ms or >3595 mV · ms, Table 6 in Reference 6) in a recent article of the LIFE study published in Hypertension.6
References
1. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949; 37: 161186.[CrossRef][Medline] [Order article via Infotrieve]
2. Casale PN, Devereux RB, Kligfield P, Eisenberg RR, Miller DH, Chaudhary BS, Phillips MC. Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. J Am Coll Cardiol. 1985; 6: 572580.[Abstract]
3. Okin PM, Roman MJ, Devereux RB, Kligfield P. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol. 1995; 25: 417423.[Abstract]
4. Alfakih K, Walters K, Jones T, Ridgway J, Hall AS, Sivananthan M. New gender-specific partition values for ECG criteria of left ventricular hypertrophy: recalibration against cardiac MRI. Hypertension. 2004; 44: 175179.
5. Ashman R, Hull E. Essential of Electrocardiography. New York; McMillan Co: 1945.
6. Vittorio Palmieri, Peter M. Okin, Jonathan N. Bella, Eva Gerdts, Kristian Wachtell, Julius Gardin, Vasilios Papademetriou, Markku S. Nieminen, Björn Dahlöf, and Richard B. Devereux. Echocardiographic wall motion abnormalities in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study. Hypertension. 2003; 41: 7582.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |